NCT Number: NCT00386867
A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
This open-label, randomized study will compare the efficacy, safety, and acceptability of mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Family Planning Associates Medical Group, Chicago, Illinois, United States
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- be willing and able to sign consent forms;
- be eligible for medical abortion according to clinician's assessment;
- be willing to undergo a surgical completion if necessary;
- have ready and easy access to a telephone and emergency transportation;
- speak English, Spanish, or have a translator available to translate for all study procedures; and,
- agree to comply with the study procedures and visit schedule.
Exclusion criteria
- Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass;
- IUD in place;
- Chronic renal failure;
- Concurrent long-term corticosteroid therapy;
- History of allergy to mifepristone, misoprostol or other prostaglandin;
- Hemorrhagic disorders or concurrent anticoagulant therapy;
- Inherited porphyrias; or
- Other serious physical or mental health conditions.
Treatment and study plan
Primary outcomes
-
efficacy
Secondary outcomes
-
acceptability
Sponsors and collaborators
Lead sponsor
Gynuity Health Projects
Other
Registry information
Important dates
- Study start
- 2006
- Study completion
- 2007
- First posted
- Oct 12, 2006
- Registry last updated
- Jun 5, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
NCT01615731
Abortion, Induced, Dilatation, Pathologic
San Jose, California, United States
View Trial DetailsMifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction
NCT00383032
Abortion, Induced
Lebanon, New Hampshire, United States
View Trial DetailsOxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
NCT02485444
Abortion, Induced, Labor Stage, Third/Drug Effects
Erzurum, Turkey (Türkiye)
View Trial DetailsMisoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
NCT02279914
Abortion, Induced
New York, United States
View Trial Details